Vaylen vs Enhance MD: Prepay Semaglutide vs Low Intro Pricing

Quick verdict: Vaylen vs Enhance MD

Vaylen and Enhance MD both offer compounded semaglutide and tirzepatide, but they target different shoppers: Vaylen emphasizes low annualized monthly rates when you prepay a 12-month plan, while Enhance MD emphasizes a low first-month price and flat-rate ongoing pricing. If you want the lowest advertised monthly rate on a prepaid annual plan choose Vaylen. If you want the cheapest entry price and stable pricing during titration choose Enhance MD.

See Vaylen prepaid plans from $83.25/mo

Key differences at a glance

The most distinctive differences are payment model and pricing presentation, available medication formats, refund and review sequencing, shipping and turnaround, and published treatment volume or credentials. Below we compare each point side by side using only the supplied facts.

Pricing model and headline rates

Vaylen publishes annualized monthly rates that require prepaying a full 12-month plan. Semaglutide injections start at $83.25 per month on the 12-month plan or $224 per month month to month. Oral semaglutide is $99 per month on the 12-month plan or $249 month to month. Tirzepatide injections are $149 per month on the 12-month plan or $299 month to month. Every 12-month rate is billed upfront in a single charge.

Enhance MD advertises a low first-month entry price: semaglutide from $49 and tirzepatide from $99 for the first month, with flat-rate pricing that stays the same at every dose after the introductory period. The ongoing flat-rate prices are higher than the first-month offers, and specific ongoing rates are published on Enhance MD material as examples.

How pricing affects risk and refunds

Vaylen requires payment before clinician review. Vaylen states a full refund is issued for that billing cycle if a clinician decides GLP-1 medication is not clinically appropriate. The model de-risks the pay-first approach by publishing a refund when not approved, but Vaylen also notes there are no published terms for unused portions of a prepaid year if you cancel mid-treatment.

Enhance MD uses a low first-month price and then applies flat-rate pricing ongoing. The supplied evidence notes first-month rates are introductory and that the ongoing flat-rate is higher, but it does not supply the same pay-first refund language as Vaylen.

Compare Enhance MD first-month pricing from $49

Medication formats and dose pricing behavior

Vaylen offers both molecules and multiple formats on one platform: weekly semaglutide injections, daily oral semaglutide tablets, and weekly tirzepatide. Vaylen highlights that oral semaglutide is a needle-free tablet and costs about $16 per month more on the prepaid 12-month plan than the injectable form of the same molecule.

Enhance MD also offers both semaglutide and tirzepatide on one platform. Its distinctive claim is flat-rate pricing that does not increase during titration, meaning the price is the same at every dose once the ongoing rate is set. Enhance MD advertises that flat-rate model as a budget feature to avoid escalation.

Turnaround, shipping and treatment volume

Vaylen promises clinician review within 24 hours and free discreet shipping in 1 to 3 business days. Vaylen also states a $0 consultation fee and inclusion of telehealth consultations by live video or asynchronous review. Vaylen indicates licensed U.S. clinicians via OpenLoop Health and availability in all 50 states.

Enhance MD notes it has treated over 10,000 patients and highlights metabolic lab testing every six months in some published rate examples. Enhance MD emphasizes flat-rate pricing and no hidden fees as dosage increases. The supplied evidence does not list the same shipping or 24-hour review promises published for Vaylen.

Comparison table

Criteria	Vaylen	Enhance MD
Starting price (semaglutide)	$83.25/mo on 12-month plan or $224/mo month to month	$49 first month, ongoing flat rate higher
Pricing model	Prepay 12-month plan billed upfront; published refund if not approved	Introductory first-month pricing then flat-rate pricing that does not escalate
Formats available	Weekly injectable semaglutide, daily oral semaglutide tablets, weekly tirzepatide	Both semaglutide and tirzepatide on one platform
Refunds and approvals	Full refund for that billing cycle if clinician declines	First-month discounts noted; no Vaylen-style refund policy supplied
Turnaround and shipping	Clinician review within 24 hours; free discreet shipping in 1 to 3 business days	10,000+ patients treated; ongoing flat-rate and metabolic lab testing examples
Regulatory note	Compounded medications are not FDA-approved finished products	Compounded medications are not FDA-approved finished products

Review Vaylen formats and prepaid pricing

Which provider suits which buyer

Choose Vaylen if you accept compounded GLP-1, want the lowest effective monthly rate on a prepaid 12-month program, need quick clinician review and fast shipping, and value a published refund if a clinician declines to prescribe. Vaylen is best for decisive buyers comfortable prepaying for an annual plan.

Start Vaylen prepaid process

Choose Enhance MD if you want the cheapest first-month entry price for semaglutide or tirzepatide and prefer flat-rate pricing that stays the same as doses increase. Enhance MD is strong for cost-sensitive patients early in treatment who want predictable per-dose billing and a provider with a large treated patient base.

See Enhance MD first-month offer

Bottom line

Vaylen vs Enhance MD comes down to prepaid annual savings and short review plus shipping times versus low entry cost and flat-rate dose pricing. Both use compounded medications and state those compounds are not FDA-approved finished products. Use this comparison to match the payment and format approach to your priorities when choosing between Vaylen and Enhance MD.